Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================

CHAMPIONS TACKLING MS - AWARDS Dinner, Honoring Aaron Boster, MD and Jon e. Glaser, DDS - now open for registration. Visit www.events.msvn.org

Saturday, February 15, 2014

Sleep Apnea May Worsen Fatigue in MS Patients

Small study suggests sleep disorder could be missed in people with multiple sclerosis
Sleep Apnea May Worsen Fatigue in MS Patients
FRIDAY, Feb. 14, 2014 (HealthDay News) -- Sleep apnea is common in people with multiple sclerosis and may contribute to their fatigue, a new study shows.
Fatigue is one of the most frequent and debilitating symptoms experienced by MS patients.
The study included 195 people with MS who completed a sleep questionnaire and were assessed for daytime sleepiness, insomnia, fatigue severity and sleep apnea.
One-fifth of the patients had been diagnosed with sleep apnea and more than half were found to have an elevated risk for the condition. The researchers also found that sleep apnea risk was a significant predictor of fatigue severity.
According to the American Academy of Sleep Medicine (AASM), sleep apnea involves decreased or periodic stoppage of airflow during sleep. As muscles relax, soft tissue at the back of the throat may collapse and block the upper airway. Most people with the condition snore loudly.
MS is a chronic, frequently disabling disease that attacks the central nervous system, according to the National Multiple Sclerosis Society. Symptoms range widely, from mild signs such as numbness in the limbs to severe symptoms including paralysis or loss of vision.
The new findings suggest that sleep apnea may be a common but under-recognized contributor to fatigue in MS patients, and doctors should not hesitate to check these patients for sleep problems, study author Dr. Tiffany Braley, an assistant professor of neurology at the University of Michigan Multiple Sclerosis and Sleep Disorders Centers, said in an AASM news release.
……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Friday, February 14, 2014

Out of the 'Shadows': Pot Sellers Can Now Do Business With Banks



Feds OK Bank Loans to Pot Dealers -

-http://www.nbcnews.com/news/us-news/out-shadows-pot-sellers-can-now-do-business-banks-n30661









……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Targeting Et-1 May Reverse Myelin Deterioration in Multiple Sclerosis

Posted by: Maureen Newman February 11, 2014
Myelin and multiple sclerosisScientists at the Center for Neuroscience Research at Children’s National Health System know it is better to treat a disease than to only treat the symptoms. Vittorio Gallo, director of the center, just published research in the journal Neuron that could lead to pharmaceuticals that reduce the rate of deterioration and actually promote growth of neurons damaged by the disease multiple sclerosis (MS).
MS is an autoimmune disease where the myelin sheath around axons is destroyed, and unable to be repaired by the body. This is because endogenous oligodendrocyte progenitor cells (OPCs), cells that give rise to other cells (oligodendrocytes) that myelinate axons in the central nervous system, fail to differentiate into effective myelinating cells. This results in chronic lesions in the brain, or deterioration that affects everything from afflicted patients’ speech to their motor coordination.
Dr. Gallo, who also serves as a professor of pediatrics at the George Washington University School of Medicine and Health Sciences (SMHS), reported in the research publication that he and his fellow researchers were able to identify a small protein that can be targeted to promote repair of damaged tissue, with therapeutic potential. The molecule, Endothelin-1 (ET-1), is shown to inhibit repair of myelin.
BioNews Texas has recently covered several promising research stories on how focusing on myelin repair and neural protection is quickly becoming the vanguard of Multiple Sclerosis research and development, as myelin damage is a hallmark characteristic of MS. The study demonstrates that blocking ET-1 pharmacologically or using a genetic approach could promote myelin repair.
“We demonstrate that ET-1 drastically reduces the rate of remyelination,” Gallo said. This creates a new drug target in the treatment of MS. Said Gallo, ET-1 is “potentially a therapeutic target to promote lesion repair in deymyelinated tissue.” It plays a “crucial role in preventing normal myelination in MS and in other demyelinating diseases.”
……..

To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Thursday, February 13, 2014

Relapsing-Remitting MS Study of Gilenya Underway

Posted by: Ayesha Khan   February 10, 2014

Relapsing-Remitting MS Study of GilenyaMultiple Sclerosis is a chronic progressive disease that often follows a relapsing-remitting course, with active episodes of exacerbations followed by periods of remission. The primary patho-physiological event is the autoimmune attack on myelin sheaths of nerves that affects the speed of nerve conduction in the brain and spinal cord. Primary symptoms include visual abnormalities, stiffening of extremities and a variety of other physical and eventually psychological issues.
So far, there are only a few viable treatment options that mainly focus on aborting an episode of exacerbation or prolonging the remission in MS patients. However, Multiple Sclerosis researchers are beginning a new study to evaluate the efficacy and therapeutic effectiveness of Gilenya (Fingolimod) in the management of MS against other disease modifying therapies.

Eligibility Criteria:

The 12-month, open level study, sponsored by Novartis, will evaluate the retention of Multiple Sclerosis patients with Fingolimod against other MS DMT regimens. Approximately 1,000 patients will be enrolled in the PREFER MS Study, with eligibility criteria that stipulates the following:
-          The study participants must be in the early stages of the relapsing-remitting form of MS and within the 18-65 year age range.
-          Participants must have a history of taking disease modifying MS therapy, with no more than 1 class of drugs, for a maximum of 5 years.
-          Participants may also be new MS patients who have not been exposed to any DMT treatments thus far for the management of MS.
Exclusion criteria includes (but is not limited to), bradycardia (resting heart rate below 45 bpm), history of malignancy or other immune disorders, ECG abnormalities, sleep apnea, pregnancy, neurological conditions, and pulmonary abnormalities.
To see how Patients will be selected, click here

……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Secondary Progressive Multiple Sclerosis EBV Adoptive Immunotherapy Shows Promise

secondary progressive multiple sclerosis and Epstein-Barr virusPosted by: Maureen Newman   February 10, 2014


Professor Michael Pender, of the University of Queensland School of Medicine, Brisbane, had a notion that patients with advanced multiple sclerosis, otherwise known as secondary progressive multiple sclerosis, have an impaired immunity to the Epstein-Barr virus(EBV).

 EBV is one of the most common viruses in humans, affecting 9 out of 10 people at some point in their lives, and is a member of the herpes family. Several studies have linked EBV to triggering patients’ MS, as increased levels of EBV antibodies have been found in MS patients’ blood and EBV-infected immune cells have been found in postmortem brains from MS patients. Although no causal relationship has been established, EBV exposure seems to increase an individual’s risk of developing MS.

Source: BioNews

……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Monday, February 10, 2014

Jonah Chan - an MS Researcher sees progress




Listen to Jonah's story  as he researches ReMylenation in Multiple Sclerosis

……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Stem Cells and MS / Future Therapy




Although this video was recorded a few years ago, there is a great deal to learn from this video

Watch and share from this link -

There is much to be learned with regards to this research and so, we hope that since this video was produced, that more has been learned.

If an update 'is' available, we would like to receive and re-post

……..

To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.

Sunday, February 9, 2014

“How MS Impacts the Family”

Forty-Four Minutes into this video, you can listen and watch Psychologist, Rick Harris EXPLAIN about “How MS Impacts the Family”




Topics Include:
Caregiver role
Fears
Economic factor
Demands
Moods
Role Change

Apprehension or Fear – for the Future



……..


To comment - click the comment link shown below
…….
Share our Articles with others
……
Sign-up at:  www.msviewsandnews.org 
To Keep CURRENT  and up to date with MS News and Information
 -------------
Donate Now Please - Click here
Thank you    
…………………….
.